Invasive Fungal Infections after Renal Transplantation
نویسندگان
چکیده
BACKGROUND Invasive fungal infection (IFI) is a leading cause of infection-related mortality among kidney allograft recipients. OBJECTIVE To estimate the incidence and etiology of systemic fungal infection in renal allograft recipients in Sydney transplant facility. METHODS 471 kidney recipients, transplanted between 2000 and 2010 at the Westmead Hospital renal transplantation center, Sydney, Australia, were retrospectively surveyed. RESULTS IFI developed in 10 (2.1%) of 471 patients. With a mean±SD new kidney transplants per year of 42.9±13, the mean±SD incidence of IFI was 0.9±0.6 for each year of transplantation. 4 patients had received kidneys from living donors and 7 from cadavers with a mean±SD age of 50.5±14 years. The mean time to IFI was 33 months after transplantation with majority within the first 2 years. Cryptococcus neoformans was responsible for 50% of episodes (n=5) followed by Aspergillus fumigatus (n=3), and Pseudallescheria boydii (n=3); there was a single case of mucurmycosis. Lungs (n=5) followed by meninges (n=4) and skin (n=3) were the most commonly involved sites. CONCLUSION IFI remains a major concern in renal transplantation. A high index of suspicion is required for early diagnosis and treatment to reduce the mortality. In this regard, appropriate diagnostic tests are necessary, particularly for C. neoformans.
منابع مشابه
Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent.
Invasive fungal infections and their risk factors were prospectively assessed in 130 consecutive liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Eleven percent (14) of the 130 patients had 17 episodes of invasive fungal infections. These included candidiasis (5%; 6 patients), cryptococcosis (5%; 6), aspergillosis (3%; 4), and chromomycosis (1%; 1). An el...
متن کاملAntifungal Prophylaxis in Liver Transplant Recipients.
Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no consensus exists on which patients should receive prophylaxis, with which agent, and for what duration...
متن کاملFungal infections of the Respiratory Tract-Section 1
Fungal infections of the Respiratory Tract are important causes of morbidity and mortality in immunocompromised hospitalized patients. Among these patients are those receiving cytotoxic chemotherapy for neoplastic diseases, those undergoing bone marrow stem cell transplantation or organ transplantation, and those affected with the acquired immune deficiency syndrome. Invasive Aspergillosis has ...
متن کاملFungal Infections in Renal Transplant Patients
Organ transplantation has always been considered to be the standard therapeutic interventions in patients with end-stage organ failure. In 2008, more than 29,000 organ transplants were performed in US. Survival rates among transplant recipients have greatly improved due to better understanding of transplant biology and more effective immunosuppressive agents. After transplant, the extent of the...
متن کاملImmunotherapy for invasive fungal infections in transplant patients: back to the future?
In the past decade, we have witnessed striking advances in the diagnosis and therapy of invasive fungal infections in immunocompromised patients. Similar to the quantum leap in HIV medicine about 15 years ago, this progress resulted from the synergy of new diagnostic assays (galactomannan antigen, beta-glucan, (pan-)fungal polymerase chain reaction), with new and better antifungal drugs such as...
متن کامل